Fintel reports that on September 21, 2023, Goldman Sachs maintained coverage of Revance Therapeutics (NASDAQ:RVNC) with a Buy recommendation. As of August 31,…
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report)’s share price hit a new 52-week low on Tuesday . The company traded as low as $11.10 and last traded at $11.23, with a volume of 1723315 shares. The stock had previously closed at $16.70. Wall Street Analysts Forecast Growth RVNC has been the subject of a […]
Revance Provides Corporate Update at Investor Day streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Revance Therapeutics (RVNC) Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.